Amy L. Burroughs, Director at DiaMedica Therapeutics Inc. (DMAC), bought 89,900 shares at $3.15 ($283K) on 2021-08-16, disclosed to the SEC on 2021-08-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.15 | 44,950 | $142K | 50.0% |
| 2 | $3.15 | 44,950 | $142K | 50.0% |
| Total | $3.15 avg | 89,900 | $283K | 100% |
| Filing → |
| TERN | SELL | 2026-01-16 | $5.1M | — | Filing → |
| TERN | SELL | 2026-01-06 | $5.4M | — | Filing → |
| TERN | BUY | 2025-06-25 | $180K | — | Filing → |